Genpact Limited (NYSE:G) Shares Sold by Dalton Investments LLC

Share on StockTwits

Dalton Investments LLC trimmed its position in Genpact Limited (NYSE:G) by 12.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 697,660 shares of the business services provider’s stock after selling 96,659 shares during the quarter. Genpact makes up approximately 12.1% of Dalton Investments LLC’s portfolio, making the stock its 2nd largest position. Dalton Investments LLC owned approximately 0.37% of Genpact worth $26,574,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the business. Envestnet Asset Management Inc. lifted its position in shares of Genpact by 8.7% in the first quarter. Envestnet Asset Management Inc. now owns 248,410 shares of the business services provider’s stock worth $8,739,000 after purchasing an additional 19,973 shares in the last quarter. Arabesque Asset Management Ltd purchased a new stake in shares of Genpact in the first quarter worth approximately $2,148,000. Sheets Smith Wealth Management purchased a new stake in shares of Genpact in the first quarter worth approximately $367,000. Citigroup Inc. lifted its position in shares of Genpact by 900.3% in the first quarter. Citigroup Inc. now owns 107,631 shares of the business services provider’s stock worth $3,786,000 after purchasing an additional 96,871 shares in the last quarter. Finally, New York State Teachers Retirement System purchased a new stake in shares of Genpact in the first quarter worth approximately $77,000. Institutional investors own 94.71% of the company’s stock.

In related news, insider Private Ltd Gic sold 1,878,196 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $40.51, for a total transaction of $76,085,719.96. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director David Humphrey sold 3,000 shares of Genpact stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $17.10, for a total transaction of $51,300.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $76,950. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,580,720 shares of company stock worth $509,578,468. Insiders own 1.86% of the company’s stock.

G has been the subject of a number of research analyst reports. Needham & Company LLC reissued a “buy” rating and issued a $48.00 price target (up from $44.00) on shares of Genpact in a research report on Thursday, August 8th. Bank of America increased their price target on shares of Genpact from $40.00 to $43.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Wedbush increased their price target on shares of Genpact from $33.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. Cantor Fitzgerald increased their price target on shares of Genpact from $40.00 to $47.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Finally, Deutsche Bank increased their price target on shares of Genpact from $36.00 to $44.00 and gave the stock a “hold” rating in a research report on Thursday, August 8th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Genpact currently has a consensus rating of “Buy” and a consensus target price of $39.70.

Shares of G opened at $39.50 on Friday. The firm has a market cap of $7.52 billion, a PE ratio of 24.69, a PEG ratio of 2.09 and a beta of 0.83. The firm’s 50 day moving average price is $40.47 and its 200 day moving average price is $37.21. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.46 and a current ratio of 1.46. Genpact Limited has a twelve month low of $25.48 and a twelve month high of $44.55.

Genpact (NYSE:G) last issued its quarterly earnings data on Wednesday, August 7th. The business services provider reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. The firm had revenue of $882.79 million for the quarter, compared to analyst estimates of $824.84 million. Genpact had a net margin of 8.77% and a return on equity of 21.87%. The company’s revenue for the quarter was up 21.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 earnings per share. On average, sell-side analysts anticipate that Genpact Limited will post 1.69 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Wednesday, September 11th will be given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 0.86%. The ex-dividend date is Tuesday, September 10th. Genpact’s payout ratio is presently 21.25%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

Featured Article: Why is the LIBOR significant?

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.